Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 289
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02118285 | Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT00895414 | Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer | ||
| NCT03728699 | Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy | ||
| NCT03674411 | Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy | ||
| NCT00617929 | Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant | ||
| NCT00432094 | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | ||
| NCT00290628 | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT03019666 | Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT06772090 | Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies | ||
| NCT00784524 | Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca | ||
| NCT00373152 | MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer | ||
| NCT00293293 | Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | ||
| NCT03365661 | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML | ||
| NCT01158456 | Metabolism of NNK Among African Americans | ||
| NCT00619021 | Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | ||
| NCT00167180 | Post Transplant Donor Lymphocyte Infusion | ||
| NCT05363267 | NF-1, Nutraceutical Intervention | ||
| NCT04530695 | Diagnosis and Treatment of Periodontal Disease in Patients With AML | ||
| NCT01012362 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | ||
| NCT03850691 | Radiation and Combination Immunotherapy for Melanoma | ||
| NCT00478244 | Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa | ||
| NCT03789721 | Adrenoleukodystrophy National Registry Study | ||
| NCT00686556 | Total Marrow Irradiation for Refractory Acute Leukemia | ||
| NCT06544811 | American Indian Smokefree Native RCT | ||
| NCT01593618 | Empowering Cancer Survivors Through Information Technology | ||
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study | ||
| NCT00005986 | Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | ||
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT04225572 | Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) | ||
| NCT03579875 | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders | ||
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | ||
| NCT00748163 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT00262951 | Chemoradiation in Locally Advanced Pancreatic Cancer | ||
| NCT00383448 | HSCT for High Risk Inherited Inborn Errors | ||
| NCT00618540 | Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis | ||
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders | ||
| NCT06692426 | Trial of Cell Based Therapy for DMD | ||
| NCT01685411 | Busulfan and Cyclophosphamide Followed By ALLO BMT | ||
| NCT06872333 | Allo HSCT for High Risk Hemoglobinopathies | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT00869323 | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders | ||
| NCT05322408 | HCW9218 in Select Advanced Solid Tumors | ||
| NCT00871689 | Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML |
